Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US8629158B2 · kind B2 · utility
0Cited by
65References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 2010 |
| Grant date | Jan 14, 2014 |
| Priority date | — |
| Expiry date | May 3, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.